Literature DB >> 4033727

Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis.

J G Fournier, M Tardieu, P Lebon, O Robain, G Ponsot, S Rozenblatt, M Bouteille.   

Abstract

To clarify the relation between lymphocytes and measles virus in subacute sclerosing panencephalitis, we used in situ hybridization and a cloned measles virus DNA probe, specific for nucleocapsid protein, to detect measles virus RNA sequences in circulating lymphocytes and brain perivascular cuffs of patients with subacute sclerosing panencephalitis. Seventy to 90 per cent of peripheral mononuclear cells from three such patients were found to contain measles virus RNA sequences. In contrast, only a few infected cells were observed in four seropositive adults (0.1 to 5 per cent) and three age-matched children (10 to 15 per cent) used as controls. In one sample of brain tissue from a patient with subacute sclerosing panencephalitis, viral RNA sequences were also detected in nerve cells and in numerous cells from the perivascular infiltrates. In contrast, no hybridization was observed in brain tissue from a patient with herpetic encephalitis and from a patient with postlymphoma encephalitis. We conclude that measles virus has a strong tropism for lymphocytes and nerve cells in subacute sclerosing panencephalitis and that lymphocytes may be involved in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033727     DOI: 10.1056/NEJM198510103131502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  The viral etiology of Paget's disease of bone: a new perspective.

Authors:  A J Kahn
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

2.  Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney.

Authors:  C Lacombe; J L Da Silva; P Bruneval; J G Fournier; F Wendling; N Casadevall; J P Camilleri; J Bariety; B Varet; P Tambourin
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Virus-specific IgA in serum, saliva, and tears of children with measles.

Authors:  M G Friedman; M Phillip; R Dagan
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  DNA probes for clinical applications. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-06       Impact factor: 2.926

5.  Subacute sclerosing panencephalitis: detection of measles virus sequences in RNA extracted from circulating lymphocytes.

Authors:  J G Fournier; J Gerfaux; A M Joret; P Lebon; S Rozenblatt
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

6.  Measles virus matrix protein gene expression in a subacute sclerosing panencephalitis patient brain and virus isolate demonstrated by cDNA hybridization and immunocytochemistry.

Authors:  H R Brown; N L Goller; H Thormar; R Rudelli; W W Tourtellotte; P Shapshak; R Boostanfar; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 7.  Chronic viral diseases.

Authors:  B Berris
Journal:  CMAJ       Date:  1986-12-01       Impact factor: 8.262

8.  Molecular pathogenesis of type 2 poliovirus in mice.

Authors:  T Couderc; B Guinguene; F Horaud; A Aubert-Combiescu; R Crainic
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

9.  Do measles early giant cells result from fusion of non-infected cells? An immunohistochemical and in situ hybridization study in a case of morbillous appendicitis.

Authors:  A Gaulier; P Sabatier; S Prevot; J G Fournier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

10.  MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line.

Authors:  J J Schnorr; S Schneider-Schaulies; A Simon-Jödicke; J Pavlovic; M A Horisberger; V ter Meulen
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.